Insurers May Cover Costly Hepatitis C Drugs Only For The Very Ill
An estimated 3.2 million people are infected with hepatitis C virus. Many public and private insurers are restricting access to treatment to those who already have serious liver damage. The treatment cost per patient is roughly $95,000 or more for a 12 ...
NPR (blog) - Tue, 28 Oct 2014 08:21

Pros and Cons of New Hepatitis C Treatments for Patients
Everyday Health - Tue, 28 Oct 2014 10:03

Some Hep C Patients May Not Get Coverage for Pricey Drugs
MedPage Today - Tue, 28 Oct 2014 14:33

Gilead's latest hepatitis C drug breaks US sales records
Financial Times - Tue, 28 Oct 2014 05:02

Sales of Gilead's pricey hepatitis C drug slow
MarketWatch - Tue, 28 Oct 2014 13:15

Sales of Gilead's Pricey Hepatitis Drug Slow
Wall Street Journal - Tue, 28 Oct 2014 13:18



Ex-WWE Wrestler Sues -- I Got Hepatitis C ... During Bloody Wrestling Match
"Since 2008, WWE has conducted physicals and blood work, including tests for Hepatitis C, as part of our Talent Wellness Program. These tests take place before a performer signs a contract and twice per year thereafter, and results are shared with the ...
TMZ.com - Wed, 29 Oct 2014 08:06

Former Wrestler Says He Contracted Hepatitis C At WWE
Business 2 Community - Wed, 29 Oct 2014 15:07

Billy Jack Haynes Sues WWE, Blames Company For His Hepatitis C Diagnosis
The Inquisitr - Wed, 29 Oct 2014 09:13

Billy Jack Haynes Is Suing WWE For Allegedly Giving Him Hep C
Uproxx - Wed, 29 Oct 2014 08:26

Wrestler Billy Jack Haynes Is Suing The WWE After He Contracted Hepatitis C!
PerezHilton.com - Thu, 30 Oct 2014 12:41

More On Billy Jack Haynes' Lawsuit Against WWE, Says He Got Hepatitis C ...
Wrestling Inc. - Wed, 29 Oct 2014 13:40



Harvoni Takes the Sting Out of Hepatitis C Treatment
Finally, there's a medication to cure hepatitis C that doesn't require use of the dreaded drugs interferon or ribavirin. The U.S. Food and Drug Administration earlier this month approved Harvoni, a once-daily tablet manufactured by Gilead Sciences ...
Healthline - Sun, 26 Oct 2014 06:07

How Gilead Sciences Inc. Isn't Gouging Hepatitis C Patients, in 1 Simple ...
Motley Fool - Sun, 26 Oct 2014 08:15



Prisons balk at Sovaldi's $84000 cost for hepatitis C treatment
In San Francisco's jails, no inmates with hepatitis C are receiving Sovaldi, the breakthrough pill that can cure most patients in an unprecedented amount of time. In California's prisons, the drug, made by Gilead Sciences of Foster City, is being given ...
SFGate - Mon, 20 Oct 2014 17:18

For inmates, pricey hepatitis C drug could make financial sense
Stanford Medical Center Report - Mon, 20 Oct 2014 14:11

Officials Say Hepatitis C Drug Too Pricey To Give to All Calif. Inmates
California Healthline - Tue, 21 Oct 2014 07:02

Despite steep price tag, use of hepatitis C drug among prisoners could save ...
Scope (blog) - Mon, 20 Oct 2014 15:41

Expensive Sovaldi drug for hepatitis C still most cost-effective choice for U ...
Tech Times - Wed, 22 Oct 2014 04:37

Gilead's $1000-a-pill hepatitis C drug may make financial sense for prisons
San Francisco Business Times (blog) - Mon, 20 Oct 2014 14:32

Giving pricey hepatitis drug to prisoners may be financially wise
Reuters - Tue, 21 Oct 2014 13:56



Regulus Gets Seat at Hep C Table With Today's Impressive Drug Results
A single injection of a microRNA therapeutic directed at a genetic target in the liver of hepatitis C patients produced a significant drop in viral load, according to interim results from an early-stage study announced Wednesday by Regulus Therapeutics ...
TheStreet.com - Wed, 22 Oct 2014 08:53

Promising hepatitis C drug = 100% gain
USA TODAY - Wed, 22 Oct 2014 14:33

Regulus soars on promising--but early--results for its hep C contender
FierceBiotech - Wed, 22 Oct 2014 06:46

Regulus Therapeutics Soars 90% On Hepatitis C Treatment News
Benzinga - Wed, 22 Oct 2014 07:37

Regulus surges on early hepatitis C drug data
Businessweek - Wed, 22 Oct 2014 10:48



Find Information About:
In clinical trials, Harvoni was so effective that it cured hepatitis C after 3 months of treatment in about 94% of people who took it. Cure rates approached 100% after 6 months of treatment in patients whose hep C was harder to treat, often because ...
WebMD - Fri, 10 Oct 2014 15:18

US FDA approves Gilead's $94500 hepatitis C drug
Reuters - Fri, 10 Oct 2014 11:12

FDA approves hepatitis C drug that costs $1125 per pill
Fox News - Fri, 10 Oct 2014 14:11

FDA approves new $1125-a-pill hepatitis C drug
CBS News - Fri, 10 Oct 2014 11:55

Business Day|Harvoni, a Hepatitis C Drug From Gilead, Wins FDA Approval
New York Times - Fri, 10 Oct 2014 11:45

Gilead Wins U.S. Approval for Hepatitis C Combo Pill
Bloomberg - Fri, 10 Oct 2014 11:07

Gilead Gets US Approval to Sell New Hepatitis C Drug
Wall Street Journal - Fri, 10 Oct 2014 10:45

Hepatitis C Reaches Historic Highs: More Than 75% of Infected are Baby Boomers
The numbers are sobering: While the U.S. Centers for Disease Control and Prevention (CDC) estimates that 3.2 million Americans are currently infected with the Hepatitis C virus (HCV), the World Health Organization (WHO) further estimates that a ...
Alaska Native News - Thu, 30 Oct 2014 10:26



Senate Lawmaker Eyes Hearing on the Cost of Hepatitis C Treatments
Responding to the ongoing controversy over the prices for new hepatitis C treatments, U.S. Sen. Bernard Sanders (I-Vt.) will probably hold a hearing – possibly before the year ends – to examine how the cost is affecting the U.S. Department of Veterans ...
Wall Street Journal (blog) - Mon, 20 Oct 2014 08:20

Will High Price Hurt Gilead Sciences' New Hep-C Drug?
Barron's (blog) - Mon, 20 Oct 2014 11:51


1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014